Isoniazid (INH) is highly bactericidal against replicating tubercule bacilli and is involved in all antituberculous chemotherapeutic regimens. Several neurological adverse effects, following both therapeutic and overdose use of INH, have been reported in adults in the literature. Here, we present a case of a 5-year-old girl with intestinal Tuberculosis, who developed hemiclonic seizure as a side effect of INH therapeutic dose after 2 weeks of tuberculosis therapy.
CITATION STYLE
Mohammad, L., Doya, L., Omran, R., Ibrahim, A., Alshehabi, Z., & Ibrahim, A. (2021). An unusual case of seizures in a 5-year-old Syrian female with abdominal tuberculosis: An isoniazid therapeutic dose side effect. Oxford Medical Case Reports, 2021(1), 22–25. https://doi.org/10.1093/omcr/omaa126
Mendeley helps you to discover research relevant for your work.